Anaplastic meningioma
MONDO:0020635A WHO grade III meningioma characterized by the presence of malignant morphologic features, including malignant cytology and a very high mitotic index (20 or more mitoses per ten high power fields).
Also known as: anaplastic (malignant) meningioma, anaplastic meningioma, malignant meningioma, meningioma, anaplastic, malignant, meningioma, malignant
2785 clinical trials for this condition and its sub-types, 9 tagged with Anaplastic meningioma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New radiation approach aims to stop brain tumor regrowth
Disease control Recruiting nowThis pilot trial is testing a type of radiation called hypofractionated stereotactic radiosurgery for people who have had surgery for a grade II or recurrent grade I meningioma. The treatment delivers higher doses of radiation in fewer sessions, which may kill leftover tumor cell…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Cancer pill shows promise against tough brain tumor
Disease control Recruiting nowThis phase 2 trial tests whether the drug regorafenib can slow tumor growth in people with recurrent meningioma, a type of brain tumor. About 104 participants will receive either regorafenib or standard care. The main goal is to see how long the tumor stays under control.
Phase 2 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Immune cells injected into brain to fight tumors
Disease control Recruiting nowThis study tests a new treatment using natural killer (NK) cells, a type of immune cell, for adults with aggressive brain tumors that have not responded to standard therapies. The NK cells are grown in a lab and then given through a vein and directly into the brain. The main goal…
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New pill shows promise in early brain tumor trial
Disease control Recruiting nowThis early-stage study tests an oral drug called ONC206 in adults with brain tumors that have come back. The main goal is to find the safest dose and check for side effects. About 102 participants will take the drug once or several times a week.
Phase 1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC